Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · Sep 25, 2018 – Jan 18, 2019 · Past |
| Heather Preston Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past) | Director · Sep 25, 2018 – Jun 19, 2019 · Past |
| Nicholas Galakatos Other companies: Tourmaline Bio Inc. (Director · May 6, 2021 – May 6, 2021 · Past); Praxis Precision Medicines, Inc. (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Aug 3, 2016 · Past); IVERIC bio Inc (Director · Sep 25, 2013 – Jan 11, 2016 · Past); NanoString Technologies Inc (Director · Jun 25, 2013 – Mar 25, 2019 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 27, 2014 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jun 1, 2011 · Past); Affymax Inc (Director · Dec 14, 2006 – May 28, 2009 · Past) | Director · Sep 25, 2018 – Jun 19, 2019 · Past |
| David Hastings Other companies: Trevi Therapeutics, Inc. (Chief Financial Officer · Since at least Dec 4, 2025); Scynexis, Inc. (Director · Since at least Sep 24, 2015); Vascular Biogenics Ltd (Director · Jan 1, 2023 – Jan 1, 2023 · Past); Arbutus Biopharma Corporation (Chief Financial Officer · Jun 11, 2018 – Feb 14, 2025 · Past); Unilife Corp (See Remarks · Feb 23, 2015 – Jan 26, 2017 · Past); Incyte Corporation (Chief Financial Officer · Jan 13, 2006 – Jun 4, 2014 · Past) | Director · Sep 25, 2018 – Jul 7, 2022 · Past |
| David Meek Other companies: Cullinan Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least May 15, 2024); uniQure N.V. (Chairman of the Board · Since at least Jun 13, 2018); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past); Baxalta Inc (EVP and President, Oncology · Jun 30, 2015 – Jun 3, 2016 · Past); Endocyte Inc (Chief Commercial Officer · Aug 3, 2012 – Feb 6, 2014 · Past) | Director · Jun 19, 2019 – Jul 7, 2022 · Past |
| Gregory Norden Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Oct 15, 2020); Royalty Pharma plc (Director · Since at least Jun 15, 2020); Zoetis Inc. (Director · Since at least Jan 31, 2013); NanoString Technologies Inc (Director · Jun 25, 2013 – May 6, 2024 · Past); Human Genome Sciences Inc (Director · Jan 20, 2011 – Jul 30, 2012 · Past) | Director · Sep 25, 2018 – Jun 19, 2019 · Past |
| Howard Mayer Other companies: PepGen Inc. (Non-Executive Director · Since at least Nov 10, 2023); Invivyd, Inc. (Director · Aug 5, 2021 – Jun 22, 2022 · Past) | Director · Aug 5, 2019 – Jul 7, 2022 · Past |
| David Altarac Other companies: Innoviva, Inc. (Chief Medical Officer, IST · Since at least Oct 19, 2026) | Chief Medical Officer · Nov 4, 2019 – Jul 7, 2022 · Past |
| Elizabeth M Keiley Other companies: Oxford Immunotec Global PLC (SVP & General Counsel · Jan 1, 2015 – Mar 4, 2019 · Past) | General Counsel · Apr 28, 2019 – Jul 7, 2022 · Past |
| Heather Berger Other companies: Design Therapeutics, Inc. (Director · Since at least Jun 15, 2021) | Director · Sep 25, 2018 – Jul 7, 2022 · Past |
| Matthew Ronsheim Other companies: Innoviva, Inc. (See Remarks · Jan 1, 2024 – May 20, 2024 · Past) | Chief of Pharma Sciences & MFG · Sep 9, 2020 – Jul 7, 2022 · Past |
| Michael Gutch Other companies: Albireo Pharma Inc (Director · Nov 3, 2016 – Mar 2, 2023 · Past) | See Remarks · Sep 25, 2018 – Jan 18, 2022 · Past |
| Andrew J Staples | Director · Sep 25, 2018 – Sep 25, 2018 · Past |
| Anna Diaz Triola | Chief Commercial Officer · Jul 19, 2021 – Jul 11, 2022 · Past |
| Eric Wilson Kimble | Chief Commercial Officer · Apr 28, 2019 – Jan 23, 2020 · Past |
| John Patrick Mueller | Chief Development Officer · Sep 25, 2018 – Jul 7, 2022 · Past |
| Kristie Ann Wagner | VP, Principal Fin & Acct Off · Feb 24, 2022 – Jul 11, 2022 · Past |
| Manoussos Perros | President and CEO, Director · Sep 25, 2018 – Jul 7, 2022 · Past |
| Robin Isaacs | Chief Medical Officer · Sep 25, 2018 – Jan 18, 2019 · Past |
| Ruben Tommasi | Chief Scientific Officer · Sep 25, 2018 – Jul 7, 2022 · Past |